Depression and Anxiety

The impact of our research

One in seven Australians will experience clinical depression in their lifetimes, and almost one in five experienced an anxiety disorder in the past year. With diagnoses of anxiety and depression on the rise, research into these disorders has never been more important.

QIMR Berghofer researchers have been running the Australian Genetics of Depression Study for more than seven years. As the world’s largest study of depression, our researchers collaborate with international scientists to identify genetic risk factors associated with depression.

We’ve collected data from more than 20,000 Australians and identified 23 genes linked to a person’s risk of developing depression. This paves the way for more tailored and effective treatments.

We’re researching what causes mood and anxiety disorders, why they run in families, and how to better diagnose them.

Our researchers have given new hope to people who experience side effects from antidepressant medication. They’ve found that genetics play an important role in whether people are impacted by headaches, insomnia, and weight gain.

About depression and anxiety

What are depression and anxiety?

Depression is a common and serious medical illness. It affects how we feel about ourselves and can make it difficult to manage day-to-day life.

Anxiety often co-occurs with depression. While it’s normal to feel occasional anxiety or worry, anxiety that becomes more constant or interferes with your social, home or work life can be a sign of an anxiety disorder.

What causes depression and anxiety?

Depression and anxiety are complex disorders. Their development is impacted by traumatic experiences, genetic factors, temperament, and interpersonal relations.

It has been estimated that over one third of the variation in depression is due to genetic factors. Biological factors may play a greater role among recurrent and early-onset depression.

Who’s most at risk of depression and anxiety?

Depression affects one in five people at some stage of their lives.

Even though females report problems with depression almost twice as often as males, the number of boys and men affected by depression is substantial – 8.8% of males experience depression in their lifetime.

Between 2011 and 2012, it’s estimated that 12.1% of all visits to general practitioners within Australia were for mental health-related issues and that 42% of these visits were by men.

What are the symptoms of depression and anxiety?

Symptoms of depression include:

  • feeling sad, down or miserable most of the time;
  • losing interest or pleasure in most of your usual activities;
  • changes in weight, appetite, and sleep patterns;
  • poor concentration;
  • lack of energy;
  • difficulty thinking.
Depression and anxiety in Australia

Mental health disorders are affected by social and economic factors, as well as other health-related circumstances.

In Australia, depression affects one in seven people and anxiety affects one in six. This isn’t isolated to adults – a recent study into adolescent mental health found almost one in seven people aged 4–17 has a mental disorder.

The 2007 National Survey of Mental Health and Wellbeing estimated that 12% of Australians are likely to experience Major Depressive Disorder (MDD) at some point in their lives. In the past 12 months, 6.2% of participants experienced an affective disorder.

Similar rates of mental health disorders have been reported in the US.

How are depression and anxiety treated?

Depression can be treated in three different ways:

  • psychological
  • physical
  • self-help.

Different types of depression respond to different kinds of treatments. Consult a health professional before undertaking treatment.

While depression can sometimes go away by itself, it may linger or get worse if left untreated. It’s important to seek support early.

Treatment options for anxiety depend on the type of anxiety and severity of the condition. They can include:

  • medicine
  • psychological therapy
  • lifestyle changes.

Facts about depression and anxiety

17%
of Australians experiencing an anxiety disorder in the last 12 months
Anxiety
is not a single condition, but a group of mental health problems
1 in 5
Australians will experience depression at some point in their lives

Our depression and anxiety research

Child and Youth Mental Health

This group conducts research across four key areas:

  • the causes and consequences of mental ill-health and suicidal behaviour in children and young people;
  • bullying, victimisation, and perpetration in school-aged children;
  • psychoneuroimmunology - they've demonstrated the interplay between the nervous system and the immune system, showing some psychosis is a result of inflammation in the central nervous system;
  • clinical trials and health service research evaluating the effectiveness of innovative treatments for young people at risk of, or living with, mental illness and the outcomes of clinical services and lifestyle support.

“The most recent comprehensive study into adolescent mental health disorders found almost one in seven people aged four to 17 — or more than 560,000 Australian children — have a mental disorder.”

Professor James Scott

Translational Neurogenomics

Patients who are diagnosed with major depressive disorder often experience different symptoms. For example, some patients with depression sleep more than usual, while others sleep less. The Translational Neurogenomics lab identified genes that are associated with symptoms of Major Depressive Disorder (MDD).

Our research aims to use the results from genetic studies, to identify more effective treatment for psychiatric disorders, including depression.

“MDD is a highly debilitating disorder and 1 in 6 Australians will experience MDD at some point in their lives. A combination of medication and therapy can be highly effective, but some patients will not respond to treatment or will have recurrent episodes of depression. Our research aims to translate the results from genetic studies to more effective treatment.”

Professor Eske Derks

Clinical Brain Networks

This group uses established and emerging neuroimaging and neuromodulation technologies to develop new therapies for mood and anxiety disorders, including major depression and obsessive-compulsive disorder.

The team employs magnetic resonance imaging, EEG, transcranial magnetic stimulation and focussed ultrasound stimulation among other approaches to uncover the brain bases of these conditions and create targeted and personalised treatments. The group focuses these efforts on the impact of the functional connectivity between brain regions on mental well-being and disorder.

“Existing pharmacological and psychological treatments for depression and OCD are effective for only a portion of people living with these debilitating conditions. Targeted, personalised brain stimulation provides a promising alternative which could finally provide relief for many.”

Associate Professor Luca Cocchi